Author:
Li Qigui,O’Neil Michael,Xie Lisa,Caridha Diana,Zeng Qiang,Zhang Jing,Pybus Brandon,Hickman Mark,Melendez Victor
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference33 articles.
1. WHO: Guidelines for the Treatment of Malaria. 2006, Geneva, Switzerland: World Health Organization, Available at:
http://www.who.int/malaria/publications/atoz/9789241547925/en/
. Accessed April 2014
2. Shiraki H, Kozar MP, Melendez V, Hudson TH, Ohrt C, Magill AJ, Lin AJ: Antimalarial activity of novel 5-aryl-8-aminoquinoline derivatives. J Med Chem. 2011, 54: 131-142. 10.1021/jm100911f.
3. Brueckner RP, Coster T, Wesche DL, Shmuklarsky M, Schuster BG: Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial. Antimicrob Agents Chemother. 1998, 42: 1293-1294.
4. Walsh DS, Wilairatana P, Tang DB, Heppner DG, Brewer TG, Krudsood S, Silachamroon U, Phumratanaprapin W, Siriyanonda D, Looareesuwan S: Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. Clin Infect Dis. 2004, 39: 1095-1103. 10.1086/424508.
5. Hale BR, Owusu-Agyei S, Fryauff DJ, Koram KA, Adjuik M, Oduro AR, Prescott WR, Baird JK, Nkrumah F, Ritchie TL, Franke ED, Binka FN, Horton J, Hoffman SL: A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. Clin Infect Dis. 2003, 36: 541-549. 10.1086/367542.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献